A clinical trial listing related to mazdutide research was updated on September 28, 2026. The study, titled "A Study of HRS-4729 Injection in Participants With Type 2 Diabetes," is registered as NCT07843862 on ClinicalTrials.gov.
The trial is listed as Phase 2 and its current status is not yet recruiting. No participants have been enrolled as of this listing date.
The registration does not include enrollment numbers, dosing details, or outcome data. No results have been posted for this study at this time.
Mazdutide remains classified as an unapproved compound used only in research settings. This trial update reflects a registration status change only and does not represent findings, efficacy data, or safety conclusions.
Readers interested in the broader context of this compound's research history can consult the compound overview for additional background.